About CardiAI
CardiAI is a Technology company based in Calgary (Canada) founded in 2017 by Anmol S Kapoor and Raman Kapoor. It offers AI-based solutions for cardiac diagnostics, monitoring, and health services. It operates on a B2B and D2C model in Technology and Healthcare sectors. Its chief executive is Anmol S Kapoor. CardiAI offers products and services including BPAro, cTnI Testing, and Genomics Solutions. Its focus areas include Health Tech, Diagnostics, AI Triaging and Virtual Care. Its competitors include GenXys, Qvella Corporation, Biolidics, Accelerate Diagnostics and Xagenic and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
CardiAI provides AI-driven technology for smart triaging and cardiac health management, including products like BPAro for blood pressure monitoring and cTnI testing for early heart damage detection. They offer diagnostic services and virtual care, partnering with healthcare providers and clients such as pharmacies. Based in Calgary, Canada, they focus on cost-effective innovations to improve patient outcomes and accessibility in emergency and remote settings.
- Headquarters Calgary, Canada
- Founders Anmol S Kapoor, Raman Kapoor
- SectorsTechnologyHealthcare
- Email••••••••
- Website cardiai.com
- Social X
Products & Services of CardiAI
CardiAI offers a comprehensive portfolio of products and services, including BPAro, cTnI Testing, and Genomics Solutions.
24-hour ambulatory blood pressure monitor for continuous cardiac monitoring.
Detects myocardial damage to aid early heart disease diagnosis and intervention.
Provides DNA-based insights for personalized cardiac and health management.
People of CardiAI
10 people are tracked at CardiAI (5 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Anmol S Kapoor | Co-Founder, Co-CEO | Leadership |
Raman Kapoor | Co-Founder, Co-CEO | Leadership |
Patrick Kirkwood | Vice President of Sales, Marketing, Investor Relations | Leadership |
Gene Vitug | Chief Medical Officer - CardiAI | Leadership |
Anmol Kapoor | Chief Executive Officer, Founder | Leadership |
kazim Hussain Syed | Assistant Operations Manager | Team |
Avneet Bhangu | Quality Assurance Specialist | Team |
Dr. Shalukiya Subendran (M.D) | Laboratory Assistant | Team |
Sidharth Singh Bhinder | Project Manager and Team Lead | Team |
Vivek Krishna, PhD, SMBA | Project Lead | Team |
Complete people profiles for CardiAI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of CardiAI
CardiAI has 10 listed competitors in our database, 4 of them funded. They include GenXys, Qvella Corporation, Biolidics, Accelerate Diagnostics and Xagenic, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genxys.com | 2014 | Vancouver, Canada | $1.33M | – | Provider of pharmacogenetic testing and a medication decision support system | |
| qvella.com | 2009 | Toronto, Canada | $39.7M | – | Develops innovative platforms for accurate and rapid bacteria diagnosis in healthcare. | |
| biolidics.com | 2009 | Singapore | – | – | Cell enrichment systems are provided for cancer diagnosis and treatment. | |
| acceleratediagnostics.com | 1987 | Tucson, United States | – | 197 | In vitro diagnostics for antibiotic-resistant infections are developed. | |
| xagenic.com | 2010 | Toronto, Canada | $59.07M | – | Rapid molecular diagnostics for infectious diseases are delivered at point-of-care. | |
| flurotech.com | 2018 | Calgary, Canada | – | – | Smart devices for in-house cannabis and hemp testing are provided. | |
| affinitybio.com | 2006 | Santa Barbara, United States | $51.8M | 21 | Rapid antimicrobial susceptibility testing devices are developed for life sciences. | |
| sqidiagnostics.com | 1999 | Toronto, Canada | – | – | Multiplexed tests and automated systems for biological testing are developed. | |
| inagene.com | 2018 | Toronto, Canada | – | – | Provider of genetic test for pain management | |
| genepoc-diagnostics.com | 2007 | Quebec, Canada | – | – | Point-of-care nucleic acid assays for infectious diseases are developed rapidly. |
Detailed competitors of CardiAI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in AI in Medical Diagnostics
10 companies that operate in the same segment as CardiAI (AI in Medical Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Early-stage investments in digital, climate, and deep science technologies. | 2011 | Mumbai, Maharashtra, India | – | USD 1.11 M | – | |
Deep tech innovation in IoT and AI for startups and enterprises in India. | 2015 | Bengaluru, Karnataka, India | – | – | – | |
Creates AI technologies for surgical planning, robotics, and cloud-based tools. | 2018 | Mumbai, Maharashtra, India | USD 120 K | – | – | |
Health services are provided via cordys.health domain. | 2022 | Netherlands | USD 947.57 K | – | – | |
Offers AI-powered digital solutions, engineering, IT services, and talent management globally. | 1992 | Bengaluru, Karnataka, India | – | USD 108.7 M | 3,441 | |
Offers AI consulting, data analytics, and product engineering for various industries. | 2014 | Ghaziabad, Uttar Pradesh, India | – | USD 1.4 M | 55 | |
An AI-powered tool for analyzing chest X-rays to support COVID interventions. | 2021 | Bengaluru, Karnataka, India | – | USD 177.48 K | 24 | |
Provides data-driven health optimization, diagnostics, and AI care for individuals and businesses. | 2016 | Bengaluru, Karnataka, India | – | USD 508.49 K | 31 | |
Venture capital investing in European HealthTech innovators for healthcare advancements. | 2021 | Munchen, Bayern, Germany | – | – | – | |
Provides medical imaging analysis for clinical trials using AI and secure data processing. | 2012 | Bengaluru, Karnataka, India | – | USD 487.68 K | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardiai
Complete news archive for CardiAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardiAI
CardiAI was founded in 2017.
CardiAI is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.
Anmol S Kapoor is the current CEO of CardiAI. They have also founded this company.
CardiAI provides AI-driven technology for smart triaging and cardiac health management, including products like BPAro for blood pressure monitoring and cTnI testing for early heart damage detection. They offer diagnostic services and virtual care, partnering with healthcare providers and clients such as pharmacies. Based in Calgary, Canada, they focus on cost-effective innovations to improve patient outcomes and accessibility in emergency and remote settings.
CardiAI's top competitors include Biolidics, Accelerate Diagnostics and Xagenic.
CardiAI offers BPAro, cTnI Testing, and Genomics Solutions.